Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bovine Cyclin-Dependent Kinase 12 (CDK12) ELISA Kit-Sandwich

Cat. No.EK12F4

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Bovine Cyclin-Dependent Kinase 12 (CDK12) ELISA Kit-Sandwich is designed for the quantitative determination of Bovine Cyclin-Dependent Kinase 12 (CDK12) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Bovine CDK12.
Target Species Bovine
Species Reactivity Bovine
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 270 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Cyclin-Dependent Kinase 12 (CDK12) is a protein kinase involved in the regulation of the cell cycle and transcription. It is part of the cyclin-dependent kinase (CDK) family. Bovine Cyclin-Dependent Kinase 12 is encoded by the CDK12 gene in cattle. It is a transcriptional CDK required for genomic stability, and it has been found to have multiple roles in gene expression and tumorigenesis.

Target/Biomarker Bovine CDK12
Target Synonym cyclin dependent kinase 12; CRKRS; cyclin-dependent kinase 12; Cdc2-related kinase, arginine/serine-rich; cell division protein kinase 12
Gene ID 511513
UniProt ID E1BB50

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Houles, T. et al. CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma. Nature communications. 2022, 13: 6457.
Inquiry Basket